Kathmandu, Feb. 11 -- The Department of Drug Administration (DDA) has recalled 'Supramox CV BID', a children's antibiotic, after the medicine was found to be substandard in laboratory testing.

The medicine's batch, FSBD 12016, was manufactured by Arya Pharmalab Pvt Ltd, a Bara-based company, and failed to meet IP 2022 standards for assay, according to the department, which is the national regulatory body for both allopathic and ayurvedic medicines.

"The test showed the drug did not contain the required strength (quantity) of medicine," said Narayan Dhakal, director general at the department. "The medicine may not work in patients if used, and their health condition could also deteriorate."

Supramox CV is a combination antibiotic medici...